Read about 7 celebrities who openly admitted using Ozempic, Mounjaro or other GLP-1 drugs for weight loss, including their ...

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

The highest dose of Eli Lilly’s investigational drug, retatrutide, helped adults with Type 2 diabetes lower their A1Cs about 2% and shed an average 33.3 pounds, or 15.3% of their body weight, in a ...

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

GLP-1 receptor agonist drugs such as Ozempic and Wegovy have shown significant benefits for people with diabetes and obesity. However, not everyone experiences the same results. Now, a study suggests ...